Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: A prospective, randomized, controlled trial

Xiu-hui Li; Shuang-jie Li; Yi Xu; Dan Wei; Qing-sheng Shi; Qing-xiong Zhu; Tong Yang; Jian-bo Ding; Yi-mei Tian; Ji-han Huang; Kun Wang; Tao Wen; Xi Zhang

doi:10.1007/s11655-016-2504-3

Your Location：

Home >

Browse articles >

Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: A prospective, randomized, controlled trial

Updated：2021-08-27

- Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: A prospective, randomized, controlled trial
- Chinese Journal of Integrative Medicine Vol. 23, Issue 12, Pages: 887-892(2017)
- Affiliations：
  
  1. Department of Integrated Traditional Chinese Medicine and Western Medicine, Beijing Youan Hospital Affiliated to Capital Medical University,Beijing,China
  2. Department of Communicable Diseases, Children’s Hospital of Hunan Province,Changsha,China
  3. Department of Pediatrics, Guangzhou Medical Center for Women and Children,Guangzhou,China
  4. Department of Pediatrics, First Hospital Affiliated to Guangxi Medical University,Nanning,China
  5. Department of Internal Medicine, Handan Maternal and Child Health Hospital,Hebei Province,Handan,China
  6. Department of Internal Medicine, Children’s Hospital of Jiangxi Province,Nanchang,China
  7. Department of Pediatrics, The People’s Hospital of Liuzhou,Guangxi Province,Liuzhou,China
  8. Center for Drug Clinical Research, Shanghai University of Chinese Medicine,Shanghai,China
  9. Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University,Beijing,China
  10. Department of Pediatrics, Kaifeng Children’s Hospital,Henan Province,Kaifeng,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-016-2504-3
  CLC：
- Published：2017，
  
  Published Online：9 July 2016，
Scan for full text
Li, Xh., Li, Sj., Xu, Y. et al. Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: A prospective, randomized, controlled trial., Chin. J. Integr. Med. 23, 887–892 (2017). https://doi.org/10.1007/s11655-016-2504-3

Xiu-hui Li, Shuang-jie Li, Yi Xu, et al. Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: A prospective, randomized, controlled trial. [J]. Chinese Journal of Integrative Medicine 23(12):887-892(2017)
Li, Xh., Li, Sj., Xu, Y. et al. Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: A prospective, randomized, controlled trial., Chin. J. Integr. Med. 23, 887–892 (2017). https://doi.org/10.1007/s11655-016-2504-3 DOI：

Xiu-hui Li, Shuang-jie Li, Yi Xu, et al. Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: A prospective, randomized, controlled trial. [J]. Chinese Journal of Integrative Medicine 23(12):887-892(2017) DOI： 10.1007/s11655-016-2504-3.

摘要

To evaluate the efficacy and safety of Chinese medicine (CM) plus Western medicine (WM) in the treatment of pediatric patients with severe hand

foot and mouth disease (HFMD) by conducting a prospective

controlled

and randomized trial. A total of 451 pediatric patients with severe HFMD were randomly assigned to receive WM therapy alone (224 cases

WM therapy group) or CM [Reduning Injection (热毒宁注射液) or Xiyanping Injection (喜炎平注射液)] plus WM therapy (227 cases

CM plus WM therapy group) for 7–10 days

according to a web-based randomization system. The primary outcome was fever clearance time

which was presented as temperature decreased half-life time. The secondary outcomes included the rate of rash/herpes disappearance within 120 h

as well as the rate for cough

runny nose

lethargy and weakness

agitation or irritability

and vomiting clearance within 120 h. The drug-related adverse events were also recorded. The temperature decreased half-life time was 40.4 h in the WM therapy group

significantly longer than 27.2 h in the CM plus WM therapy group (P<0.01). Moreover

the rate for rash/herpes disappearance within 120 h was 43.6% (99/227) in the CM plus WM therapy group

significantly higher than 29.5% (66/224) in the WM therapy group (P<0.01). In addition

the rate for cough

lethargy and weakness

agitation or irritability disappearance within 120 h was 32.6% (74/227) in the CM plus WM therapy group

significantly higher than 19.2% (43/224) in the WM therapy group (P<0.01). No drug-related adverse events were observed during the course of the study. The combined CM and WM therapy achieved a better therapeutic efficacy in treating severe HFMD than the WM therapy alone. Reduning or Xiyanping Injections may become an important complementary therapy to WM for relieving the symptoms of severe HFMD. (Registration No. NCT01145664)

Abstract

To evaluate the efficacy and safety of Chinese medicine (CM) plus Western medicine (WM) in the treatment of pediatric patients with severe hand

foot and mouth disease (HFMD) by conducting a prospective

controlled

and randomized trial. A total of 451 pediatric patients with severe HFMD were randomly assigned to receive WM therapy alone (224 cases

WM therapy group) or CM [Reduning Injection (热毒宁注射液) or Xiyanping Injection (喜炎平注射液)] plus WM therapy (227 cases

CM plus WM therapy group) for 7–10 days

according to a web-based randomization system. The primary outcome was fever clearance time

which was presented as temperature decreased half-life time. The secondary outcomes included the rate of rash/herpes disappearance within 120 h

as well as the rate for cough

runny nose

lethargy and weakness

agitation or irritability

and vomiting clearance within 120 h. The drug-related adverse events were also recorded. The temperature decreased half-life time was 40.4 h in the WM therapy group

significantly longer than 27.2 h in the CM plus WM therapy group (P<0.01). Moreover

the rate for rash/herpes disappearance within 120 h was 43.6% (99/227) in the CM plus WM therapy group

significantly higher than 29.5% (66/224) in the WM therapy group (P<0.01). In addition

the rate for cough

lethargy and weakness

agitation or irritability disappearance within 120 h was 32.6% (74/227) in the CM plus WM therapy group

关键词

handfoot and mouth diseaseReduning InjectionXiyanping InjectionChinese Medicine

Keywords

handfoot and mouth diseaseReduning InjectionXiyanping InjectionChinese Medicine

references

Fan X, Jiang J, Liu Y, Huang X, Wang P, Liu L, et al. Detection of human enterovirus 71 and coxsackievirus A16 in an outbreak of hand, foot, and mouth disease in Henan Province, China in 2009. Virus Genes 2013;46:1–9.

Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL, Quak SH, et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis 2010;14:e1076-e101081.

Zhu J, Luo Z, Wang J, Xu Z, Chen H, Fan D, et al. Phylogenetic analysis of enterovirus 71 circulating in Beijing, China from 2007 to 2009. PloS One 2013;8:e56318.

Zhang J, Sun J, Chang Z, Zhang W, Wang Z, Feng Z. Characterization of hand, foot, and mouth disease in China between 2008 and 2009. Biomed Environ Sci 2011;24:214–221.

Zhou H, Guo S, Zhou H, Zhu Y, Zhang L, Zhang W. Clinical characteristics of hand, foot and mouth disease in Harbin and the prediction of severe cases. Chin Med J 2012;125:1261–1265.

Zhu Q, Hao Y, Ma J, Yu S, Wang Y. Surveillance of hand, foot, and mouth disease in mainland China (2008–2009). Biomed Environ Sci 2011;24:349–356.

National Health and Family Planning Commission of the People's Republic of China. Report of epidemic situation of infectious disease in China from January of 2010 to January of 2011. Available at http://www.moh.gov.cn/publicfiles/ business/htmlfiles/mohjbyfkzj/s3578/201102/50646.htm.

Tian H, Yang QZ, Liang J, Dong SY, Liu ZJ, Wang LX. Clinical features and management outcomes of severe hand, foot and mouth disease. Med Princ Pract 2012;21:355–359.

National Health and Family Planning Commission of the People's Republic of China. Guideline for the diagnosis and treatment of hand foot and mouth disease, Beijing, China, 2010. Available at http://www.nhfpc.gov.cn/mohyzs/ s3586/201004/46884.shtml

Xue B, Yao Z, Yu R. Studies on anti-EV71 virus activity of traditional Chinese medicine and its clinical application in treatment of HFMD. China J Chin Mater Med (Chin) 2011;36:3366–3370.

Lin TY, Liu YC, Jheng JR, Tsai HP, Jan JT, Wong WR, et al. Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities. Am J Chin Med 2009;37:143–158.

Mu Y, Chen X, Zhang A. Effect of Reduning Injection on HFMD in children: a randomized controlled trial. Chin J Integr Tradit West Med (Chin) 2011;31:1209–1212.

Li X, Zhang C, Shi Q, Yang T, Zhu Q, Tian Y, et al. Improving the efficacy of conventional therapy by adding andrographolide sulfonate in the treatment of severe hand, foot, and mouth disease: a randomized controlled trial. Evid Based Complement Alternat Med 2013;2013:316250.

Cao H, Liu Z, Steinmann P, Mu Y, Luo H, Liu J. Chinese herbal medicines for treatment of hand, foot and mouth disease: a systematic review of randomized clinical trials. Eur J Integr Med 2012;4:e85-e111.

Pharmacopoeia Committee of People's Republic of China. Chinese pharmacopoeia. Beijing: Chemical Industry Press;2005.

Wang C, Cao B, Liu QQ, Zou ZQ, Liang ZA, Gu L, et al. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med 2011;155:217–225.

Zu M, Zhou D, Gao L, Liu A, Du G. Evaluation of Chinese traditional patent medicines against influenza virus in vitro. Acta Pharmaceut Sinica (Chin) 2010;45:408–412.

Lu C, Liu X, Ding X, Chen X, Fan H, Liu Y, et al. A metabolomics profiling study in hand-foot-and-mouth disease and modulated pathways of clinical intervention using liquid chromatography/quadrupole time-of-flight mass spectrometry. Evid Based Complement Alternat Med 2013;2013:647452.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Pattern Classification of Enterovirus 71-Associated Hand, Foot, and Mouth Disease in Chinese Medicine: A Retrospective Study in 433 Cases

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients

Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome

Anti-inflammatory effects of Reduning Injection (热毒宁注射液) on lipopolysaccharide-induced acute lung injury of rats

Related Author

No data

Related Institution

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

Georg-August-Universität Göttingen, Göttingen

The Key Laboratory of Geriatrics, Beijing Hospital and Beijing Institute of Geriatrics’ Ministry of Public Health

Medical Informatics Center, Peking University

Department of Hospital Management, Peking University Health Science Center, Peking University

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰